CCRT group (n = 90) | NACT group (n = 38) | P-value | |||
---|---|---|---|---|---|
Characteristics | No. | % | No. | % | |
Age, years | 0.95 | ||||
Range | 15.7 - 81.5 | 22.9 - 73.0 | |||
Median | 48.2 | 48.2 | |||
Mean | 47.9 | 47.8 | |||
Gender | 0.347 | ||||
Male | 73 | 81.1 | 28 | 73.7 | |
Female | 17 | 18.9 | 10 | 26.3 | |
WHO Classification | 0.941 | ||||
Type I | 4 | 4.4 | 2 | 5.3 | |
Type II | 31 | 34.4 | 12 | 31.6 | |
Type III | 55 | 61.1 | 24 | 63.2 | |
T stage | 0.200 | ||||
T1 to T2 | 56 | 62.2 | 19 | 50 | |
T3 to T4 | 34 | 37.8 | 19 | 50 | |
N stage | 0.029 | ||||
N0 to N1 | 29 | 32.2 | 5 | 13.2 | |
N2 to N3 | 61 | 67.8 | 33 | 86.8 | |
Overall Stage | 0.002 | ||||
IIB-III | 66 | 73.3 | 17 | 44.8 | |
IVA-IVB | 24 | 26.7 | 21 | 55.2 |